Cargando…
Circulating Fibroblast Growth Factor 21 is Associated with Diastolic Dysfunction in Heart Failure Patients with Preserved Ejection Fraction
Fibroblast growth factor 21 (FGF21), a polypeptide ligand promoted glucose homeostasis and lipids metabolism, was recently reported to attenuate cardiac hypertrophy. The aim of this study was to investigate the impact of FGF21 in diastolic heart failure. Subjects admitted for coronary angiogram were...
Autores principales: | Chou, Ruey-Hsing, Huang, Po-Hsun, Hsu, Chien-Yi, Chang, Chun-Chin, Leu, Hsin-Bang, Huang, Chin-Chou, Chen, Jaw-Wen, Lin, Shing-Jong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5030655/ https://www.ncbi.nlm.nih.gov/pubmed/27650781 http://dx.doi.org/10.1038/srep33953 |
Ejemplares similares
-
Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
por: Wu, Cheng-Hsueh, et al.
Publicado: (2018) -
Author Correction: Circulating Fibroblast Growth Factor 21 is Associated with Subsequent Renal Injury Events in Patients Undergoing Coronary Angiography
por: Wu, Cheng-Hsueh, et al.
Publicado: (2018) -
Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients
por: Hsu, Chien-Yi, et al.
Publicado: (2013) -
Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions
por: Chiang, Chia-Hung, et al.
Publicado: (2014) -
Diastolic Ventricular Interaction in Heart Failure With Preserved Ejection Fraction
por: Parasuraman, Sathish K., et al.
Publicado: (2019)